NM_001849.4:c.1336G>A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6
The NM_001849.4(COL6A2):c.1336G>A(p.Asp446Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000881 in 1,507,332 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D446H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Publications
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1BInheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
- Bethlem myopathy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myosclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A2 | NM_001849.4 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 16 of 28 | ENST00000300527.9 | NP_001840.3 | |
| COL6A2 | NM_058174.3 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 16 of 28 | NP_478054.2 | ||
| COL6A2 | NM_058175.3 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 16 of 28 | NP_478055.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL6A2 | ENST00000300527.9 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 16 of 28 | 1 | NM_001849.4 | ENSP00000300527.4 | ||
| COL6A2 | ENST00000397763.6 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 16 of 28 | 5 | ENSP00000380870.1 | |||
| COL6A2 | ENST00000409416.6 | c.1336G>A | p.Asp446Asn | missense_variant | Exon 15 of 27 | 5 | ENSP00000387115.1 | |||
| COL6A2 | ENST00000413758.1 | c.-42G>A | upstream_gene_variant | 3 | ENSP00000395751.1 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152176Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.000418 AC: 45AN: 107528 AF XY: 0.000404 show subpopulations
GnomAD4 exome AF: 0.000916 AC: 1241AN: 1355156Hom.: 1 Cov.: 32 AF XY: 0.000884 AC XY: 590AN XY: 667224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000572 AC: 87AN: 152176Hom.: 0 Cov.: 34 AF XY: 0.000457 AC XY: 34AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
- -
Reported previously as a variant of uncertain clinical significance in multiple individuals with limb-girdle muscular dystrophy in published literature (PMID: 27854218, 30564623); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30564623, 23040494, 27854218, 31127727) -
- -
not specified Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
- -
Ullrich congenital muscular dystrophy 1A Uncertain:1
This sequence variant is a single nucleotide substitution (G>A) at coding position 1336 of the COL6A2 gene that results in an aspartic acid to asparagine amino acid change at residue 446 of the COL6A2 protein. The Asp446 residue falls in the triple helical domain which plays a critical role in the proper assembly of collagen VI (PMID: 20301676). This is a previously reported variant (ClinVar) that has been reported in a study of individuals affected by a myopathy (PMID:27854218). This variant is present in 60 of 138,852 (0.04%) alleles in the gnomAD population database. Multiple bioinformatic tools predict that this aspartic acid to asparagine amino acid change would be damaging, and the aspartic acid residue is highly conserved at this position across the vertebrate species examined. Studies examining the functiol consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PP3 -
Myosclerosis Benign:1
- -
Collagen 6-related myopathy Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bethlem myopathy 1A Benign:1
- -
Ullrich congenital muscular dystrophy 1A;CN029274:Bethlem myopathy 1A;CN117976:Collagen 6-related myopathy Other:1
Variant interpreted as Uncertain significance and reported on 05-08-2018 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at